A detailed history of First Trust Advisors LP transactions in Glaukos Corp stock. As of the latest transaction made, First Trust Advisors LP holds 80,849 shares of GKOS stock, worth $12.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
80,849
Previous 67,846 19.17%
Holding current value
$12.9 Million
Previous $8.03 Million 31.19%
% of portfolio
0.01%
Previous 0.01%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$113.62 - $135.39 $1.48 Million - $1.76 Million
13,003 Added 19.17%
80,849 $10.5 Million
Q2 2024

Aug 13, 2024

BUY
$89.48 - $118.35 $2.92 Million - $3.86 Million
32,594 Added 92.46%
67,846 $8.03 Million
Q1 2024

May 13, 2024

SELL
$76.4 - $96.33 $1.22 Million - $1.54 Million
-15,967 Reduced 31.17%
35,252 $3.32 Million
Q4 2023

Feb 13, 2024

SELL
$59.53 - $85.11 $406,054 - $580,535
-6,821 Reduced 11.75%
51,219 $4.07 Million
Q3 2023

Nov 13, 2023

BUY
$69.23 - $79.09 $3.56 Million - $4.07 Million
51,445 Added 780.06%
58,040 $4.37 Million
Q2 2023

Aug 14, 2023

SELL
$45.44 - $71.21 $8,951 - $14,028
-197 Reduced 2.9%
6,595 $469,000
Q1 2023

May 15, 2023

SELL
$43.88 - $52.48 $1.56 Million - $1.86 Million
-35,528 Reduced 83.95%
6,792 $340,000
Q4 2022

Feb 09, 2023

SELL
$40.82 - $57.75 $111,642 - $157,946
-2,735 Reduced 6.07%
42,320 $1.85 Million
Q3 2022

Nov 14, 2022

BUY
$46.84 - $58.49 $2.11 Million - $2.64 Million
45,055 New
45,055 $2.4 Million
Q2 2022

Aug 12, 2022

SELL
$34.86 - $63.77 $316,005 - $578,075
-9,065 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$44.33 - $57.82 $401,851 - $524,138
9,065 New
9,065 $524,000
Q4 2021

Feb 08, 2022

SELL
$40.27 - $56.99 $1.13 Million - $1.6 Million
-28,008 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$47.43 - $84.23 $644,478 - $1.14 Million
-13,588 Reduced 32.67%
28,008 $1.35 Million
Q2 2021

Aug 16, 2021

BUY
$73.06 - $97.7 $521,210 - $696,991
7,134 Added 20.7%
41,596 $3.53 Million
Q1 2021

May 14, 2021

BUY
$70.43 - $97.42 $1.24 Million - $1.71 Million
17,545 Added 103.71%
34,462 $2.89 Million
Q4 2020

Feb 02, 2021

BUY
$48.9 - $75.26 $827,241 - $1.27 Million
16,917 New
16,917 $1.27 Million
Q4 2019

Feb 03, 2020

SELL
$54.18 - $65.64 $3.9 Million - $4.72 Million
-71,951 Closed
0 $0
Q3 2019

Nov 04, 2019

SELL
$58.58 - $83.91 $195,247 - $279,672
-3,333 Reduced 4.43%
71,951 $4.5 Million
Q2 2019

Jul 30, 2019

SELL
$63.59 - $78.71 $380,967 - $471,551
-5,991 Reduced 7.37%
75,284 $5.68 Million
Q1 2019

May 09, 2019

SELL
$50.75 - $80.54 $1.17 Million - $1.86 Million
-23,138 Reduced 22.16%
81,275 $6.37 Million
Q4 2018

Feb 07, 2019

BUY
$52.18 - $67.93 $426,206 - $554,852
8,168 Added 8.49%
104,413 $5.87 Million
Q3 2018

Oct 25, 2018

BUY
$38.13 - $68.37 $2.22 Million - $3.98 Million
58,273 Added 153.46%
96,245 $6.25 Million
Q2 2018

Aug 02, 2018

BUY
$27.62 - $44.51 $1.05 Million - $1.69 Million
37,972 New
37,972 $1.54 Million
Q4 2017

Feb 08, 2018

SELL
$24.5 - $36.01 $573,471 - $842,886
-23,407 Closed
0 $0
Q3 2017

Oct 24, 2017

BUY
$31.26 - $42.03 $731,702 - $983,796
23,407
23,407 $772,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.57B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.